Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.55 |
| ▸ | MEN1 | O00255 | 3/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.50 |
| ▸ | THRB | P10828 | 1/20 | 0.50 |
| ▸ | HTT | P42858 | 1/20 | 0.50 |
| ▸ | MAPT | P10636 | 1/20 | 0.50 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.35 |
| ▸ | USP2 | O75604 | 2/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.33 |
| ▸ | CASP1 | P29466 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | SLCO1B3 | Q9NPD5 | 1/20 | 0.33 |
| ▸ | SLCO1B1 | Q9Y6L6 | 1/20 | 0.33 |
| ▸ | ACHE | P22303 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10030114 | 1.00 | TSHR (0.55) | TSHRMEN1KMT2ATHRBHTT | |
| SCHEMBL9962957 | 1.00 | TSHR (0.55) | TSHRMEN1KMT2ATHRBHTT | |
| SCHEMBL16706197 | 0.98 | TSHR (0.53) | TSHRMEN1KMT2ATHRBHTT | |
| SCHEMBL16706193 | 0.98 | TSHR (0.53) | TSHRMEN1KMT2ATHRBHTT | |
| SCHEMBL20462803 | 0.93 | TSHR (0.45) | TSHRMEN1KMT2ATHRBHTT | |
| SCHEMBL18961414 | 0.93 | TSHR (0.50) | TSHRMEN1KMT2ATHRBHTT | |
| SCHEMBL15297869 | 0.93 | TSHR (0.50) | TSHRMEN1KMT2ATHRBHTT | |
| SCHEMBL20462807 | 0.93 | TSHR (0.50) | TSHRMEN1KMT2ATHRBHTT | |
| SCHEMBL20462804 | 0.93 | TSHR (0.50) | TSHRMEN1KMT2ATHRBHTT | |
| SCHEMBL47736 | 0.93 | TSHR (0.59) | TSHRMEN1KMT2ATHRBHTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 132 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4704575-A2 | HYDROPHOBIC AND HYDROPHILIC MODIFIED MALEATED NATURAL OILS, SALTS AND ITS AGRICULTURAL COMPOSITIONS AND METHODS OF USE | ISP Investments LLC (US) | 2026-03-11 | — | — | EP | claimed |
| EP-4683973-A2 | DISPERSANT COMPOSITIONS COMPRISING HYDROPHOBIC AND HYDROPHILIC MODIFIED MALEATED NATURAL OILS, AND APPLICATIONS THEREOF | ISP Investments LLC (US) | 2026-01-28 | — | — | EP | claimed |
| EP-4683510-A1 | HYDROPHOBIC AND HYDROPHILIC MODIFIED MALEATED NATURAL OILS AND AGRICULTURAL COMPOSITIONS THEREOF | ISP Investments LLC (US) | 2026-01-28 | — | — | EP | claimed |
| US-20260002090-A1 | HYDROPHOBIC AND HYDROPHILIC MODIFIED MALEATED NATURAL OILS AND COMPOSITIONS THEREOF | ISP INVESTMENTS LLC (US) | 2026-01-01 | — | — | US | claimed |
| EP-4532608-A1 | HYDROPHOBIC AND HYDROPHILIC MODIFIED MALEATED NATURAL OILS AND COMPOSITIONS THEREOF | ISP Investments LLC (US) | 2025-04-09 | — | — | EP | claimed |
| WO-2025059043-A1 | A MODIFIED MALEATED NATURAL OIL CONTAINING A LACTAM MOIETY, SALTS, COMPOSITIONS, AND USE THEREOF | ISP INVESTMENTS LLC (US) | 2025-03-20 | — | — | WO | claimed |
| WO-2025059020-A1 | DISPERSANT COMPRISING MODIFIED MALEATED NATURAL OIL CONTAINING A LACTAM MOIETY, SALTS FOR CARBON NANOTUBES AND CARBON NANOTUBE COMPOSITION | ISP INVESTMENTS LLC (US) | 2025-03-20 | — | — | WO | claimed |
| WO-2025054348-A1 | DISPERSANT COMPRISING HYDROPHOBIC AND HYDROPHILIC MODIFIED MALEATED NATURAL OIL SALTS FOR CARBON NANOTUBES AND CARBON NANOTUBE COMPOSITION | ISP INVESTMENTS LLC (US) | 2025-03-13 | — | — | WO | claimed |
| WO-2025054257-A1 | MODIFIED MALEATED NATURAL OIL BASED REACTION PRODUCT AND SLURRY COMPOSITIONS CONTAINING THE REACTION PRODUCT | ISP INVESTMENTS LLC (US) | 2025-03-13 | — | — | WO | claimed |
| US-20250000772-A1 | HYDROPHOBIC AND HYDROPHILIC MODIFIED MALEATED NATURAL OILS, SALTS, COMPOSITIONS, AND METHODS OF USE | ISP INVESTMENTS LLC (US) | 2025-01-02 | — | — | US | claimed |
| US-20240368404-A1 | HYDROPHOBIC AND HYDROPHILIC MODIFIED MALEATED NATURAL OILS AND COMPOSITIONS THEREOF | ISP INVESTMENTS LLC (US) | 2024-11-07 | — | — | US | claimed |
| WO-2024229189-A2 | HYDROPHOBIC AND HYDROPHILIC MODIFIED MALEATED NATURAL OILS, SALTS AND ITS AGRICULTURAL COMPOSITIONS AND METHODS OF USE | ISP INVESTMENTS LLC (US) | 2024-11-07 | — | — | WO | claimed |
| WO-2024197173-A2 | DISPERSANT COMPOSITIONS COMPRISING HYDROPHOBIC AND HYDROPHILIC MODIFIED MALEATED NATURAL OILS, AND APPLICATIONS THEREOF | ISP INVESTMENTS LLC (US) | 2024-09-26 | — | — | WO | claimed |
| WO-2024197212-A1 | HYDROPHOBIC AND HYDROPHILIC MODIFIED MALEATED NATURAL OILS AND AGRICULTURAL COMPOSITIONS THEREOF | ISP INVESTMENTS LLC (US) | 2024-09-26 | — | — | WO | claimed |
| EP-4426760-A1 | HYDROPHOBIC AND HYDROPHILIC MODIFIED MALEATED NATURAL OILS, SALTS, COMPOSITIONS, AND METHODS OF USE | ISP Investments LLC (US) | 2024-09-11 | — | — | EP | claimed |
| EP-4405424-A1 | HYDROPHOBIC AND HYDROPHILIC MODIFIED MALEATED NATURAL OILS AND COMPOSITIONS THEREOF | ISP Investments LLC (US) | 2024-07-31 | — | — | EP | claimed |
| EP-3365108-B1 | FILLER FLUID FOR FLUIDIC DEVICES | ILLUMINA INC (US) | 2024-06-12 | — | — | EP | claimed |
| WO-2023235637-A1 | HYDROPHOBIC AND HYDROPHILIC MODIFIED MALEATED NATURAL OILS AND COMPOSITIONS THEREOF | ISP INVESTMENTS LLC (US) | 2023-12-07 | — | — | WO | claimed |
| WO-2023081006-A1 | HYDROPHOBIC AND HYDROPHILIC MODIFIED MALEATED NATURAL OILS, SALTS, COMPOSITIONS, AND METHODS OF USE | ISP INVESTMENTS LLC (US) | 2023-05-11 | — | — | WO | claimed |
| WO-2023043593-A1 | HYDROPHOBIC AND HYDROPHILIC MODIFIED MALEATED NATURAL OILS AND COMPOSITIONS THEREOF | ISP INVESTMENTS LLC (US) | 2023-03-23 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250000772-A1 | HYDROPHOBIC AND HYDROPHILIC MODIFIED MALEATED NATURAL OILS, SALTS, COMPOSITIONS, AND METHODS OF USE | LIPA, HIRA, MLEC | TSHR 4124/4885MEN1 518/4885KMT2A 3140/4885 |
| US-20240368404-A1 | HYDROPHOBIC AND HYDROPHILIC MODIFIED MALEATED NATURAL OILS AND COMPOSITIONS THEREOF | LIPA, SQLE, GK | TSHR 4513/4885MEN1 395/4885KMT2A 3429/4885 |
| US-20260002090-A1 | HYDROPHOBIC AND HYDROPHILIC MODIFIED MALEATED NATURAL OILS AND COMPOSITIONS THEREOF | CUTA, KRT18, HACD3 | TSHR 3535/4885MEN1 997/4885KMT2A 3676/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.